Citations

Clear

590 citation(s) found for "Ho, Ben".

Ultrasound-Based Visual Servoing for Out-of-Plane Longitudinal Needle Tracking in Robot-Aided Percutaneous Nephrolithotomy
Mazdarani, Hoorieh , Sainsbury, Ben , Watterson, James, Hibbert, Rebecca , Rossa, Carlos

Mayo Clinic

IEEE Access | April 17, 2025 | Volume: 13 | Issue: No issue available | Pages: 69090-69102

10.1109/access.2025.3562078 Get It

Pridopidine for the Treatment of ALS–Improvements in the Subgroup of Definite, Probable, and Early (
Geva, Michal , Meltzer, May, Cohen, Yaël C. , Hand, Randal, Leitner, Melanie , Shefner, Jeremy M. , Oskarsson, Björn , Lichtenstein, Rachel G. , Meltzer, May, Chen, Kelly , Paganoni, Sabrina , Cudkowicz, Merit , Hayden, Michael R.

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211988 Get It

Algorithm to Identify Type 2 Diabetes Using Electronic Health Record and Self-Reported Data
Varghese, Ben , Girardo, Marlene , Gupta, Ruchi , Duellman, Madison, Egan, Aoife M. , Vella, Adrian , Bailey, Kent R. , Varghese, Ben T , Egan, A M , Vella, Adrian , Dugani, Sagar B , Gupta, Ruchi, Fischer, Karen M. , Mielke, Michelle M. , Olson, Janet E. , Dugani, Sagar B.

Mayo Clinic

Metabolic Syndrome and Related Disorders | April 7, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1089/met.2024.0133 | PMID 40192533 Get It

Risk of cardiovascular disease in people with narcolepsy: a plain language summary of publication
Black, Jed , Smith, R. Brian, Dabrowski, Elizabeth , Taylor, Ben , Somers, Virend K.

Mayo Clinic

Future Cardiology | April 3, 2025 | Volume: 21 | Issue: 6 | Pages: 339-348

10.1080/14796678.2025.2482383 | PMID 40176411 Get It

Cardiac Transplantation: Physiology and Natural History of the Transplanted Heart
Alnsasra, Hilmi , Villavicencio, Mauricio A. , Daly, Richard C., Kushwaha, Sudhir S. , Asleh, Rabea

Mayo Clinic

Comprehensive Physiology | April 2, 2025 | Volume: 13 | Issue: 3 | Pages: 4719-4765

10.1002/j.2040-4603.2023.tb00267.x Get It

Abstract Heart transplantation (HT) is one of the prodigious achievements in modern medicine and remains the cornerstone in the treatment of patients with advanced heart failure. Advances in surgical techniques, immunosuppression, organ preservation, infection control, and allograft surveillance have improved short‐ and long‐term outcomes thereby contributing to greater clinical success of HT. However, prolonged allograft and patient survival following HT are still largely restricted by the development of late complications, including allograft rejection, infection, cardiac allograft vasculopathy (CAV), and malignancy. The introduction of mTOR inhibitors early after HT has demonstrated multiple protective effects against CAV progression, renal dysfunction, and tumorigenesis. Therefore, several HT programs increasingly use mTOR inhibitors with partial or complete withdrawal of calcineurin inhibitor (CNI) in stable HT patients to reduce complications risk and improve long‐term outcomes. Furthermore, despite a substantial improvement in exercise capacity and health‐related quality of life after HT as compared to advanced heart failure patients, most HT recipients remain with a 30% to 50% lower peak oxygen consumption (Vo 2 ) than that of age‐matched healthy subjects. Several factors, including alterations in central hemodynamics, HT‐related complications and alterations in the musculoskeletal system, and peripheral physiological abnormalities, presumably contribute to the reduced exercise capacity following HT. Cardiac denervation and subsequent loss of sympathetic and parasympathetic regulation are responsible for various physiological alterations in the cardiovascular system, which contributes to restricted exercise tolerance. Restoration of cardiac innervation may improve exercise capacity and quality of life, but the reinnervation process is only partial even several years after HT. Multiple studies have shown that aerobic and strengthening exercise interventions improve exercise capacity by increasing maximal heart rate, chronotropic response, and peak Vo 2 after HT. Novel exercise modalities, such as high‐intensity interval training (HIT), have been proven as safe and effective for further improvement in exercise capacity, including among de novo HT recipients. Further developments have recently emerged, including donor heart preservation techniques, noninvasive CAV and rejection surveillance methods, and improvements in immunosuppressive therapies, all aiming at increasing donor availability and improving late survival after HT. © 2023 American Physiological Society. Compr Physiol 13:4719‐4765, 2023.
MRI Findings of Facet Joint Septic Arthritis
Weger, Kendal L. , Mark, Ian T. , Gallagher, Clare, Johnson-Tesch, Ben A. , Mark, Ian , Gallagher, Clare, Hoxworth, Joseph M. , Tande, Aaron J. , Carr, Carrie M.

Mayo Clinic

Clinical Neuroimaging | April 1, 2025 | Volume: 2 | Issue: 1 | Pages: No page available

10.1002/neo2.70015 Get It

ABSTRACT Background Facet Joint Septic Arthritis (FJSA) is an infection of the spinal facet joints, for which previously described imaging findings are non‐specific. We present MRI findings of 20 patients who underwent facet biopsy for possible FJSA. Materials and Methods An internal database was reviewed for cases who underwent image‐guided spinal facet biopsy for possible infection and had pre‐biopsy contrast‐enhanced MRI. Cases were categorized as biopsy FJSA positive or negative and MRI was reviewed for synovitis, bone marrow enhancement, epidural phlegmon/abscess, and paraspinal muscle enhancement. The MRI findings were considered extensive if the involvement of the posterior paraspinal muscles spanned at least two vertebral bodies in the craniocaudal direction and at least half the length of the muscles in the anterior‐posterior direction. Results Twenty patients were included. Nine patients were FJSA positive, all of whom had synovitis, bone marrow enhancement of the facet joints, and epidural phlegmon. No patients had epidural abscess, but five patients had a paraspinal abscess. All nine patients demonstrated extensive paraspinal muscular enhancement. Eleven biopsy cases that were negative for FSJA were included. Their MRI findings demonstrated all with synovitis, six with bone marrow enhancement of the facet joints, six with epidural phlegmon, none with epidural abscess, and none with paraspinal abscess. Only one FJSA negative case had extensive paraspinal muscle enhancement. Conclusion The MRI appearance of FJSA has rarely been described in the literature; however, the diagnosis has a significant clinical impact. Facet enhancement with florid posterior paraspinal muscle enhancement should raise suspicion for FSJA.
Women Physicians in Leadership Roles in Critical Care Medicine or Academic Medicine—A Systematic Literature Review
Siddiqui, Shahla , Gali, Bhargavi , Cotter, Elizabeth , Short, Margo, McNichol, Megan , Mulaikal, Teresa A., Cassavaugh, Jessica , Chow, Jarva, Russell, Cortessa, Golhar, Shweta Yemul, Ben-Jacob, Talia K., Siddiqui, Shahla

Mayo Clinic

Critical Care Explorations | March 30, 2025 | Volume: 7 | Issue: 4 | Pages: e1249

10.1097/cce.0000000000001249 | PMID 40153554 Get It

OBJECTIVE: To systematically review and synthesize the evidence surrounding factors impacting women rising to leadership positions in critical care medicine (CCM). DATA SOURCES: PubMed, Embase, Web of Science, and Cochrane Library from 2011 to 2024. STUDY SELECTION: Articles included were cohort studies, surveys, and interviews addressing women physicians practicing in CCM and related fields of academic medicine. DATA EXTRACTION: Causes of not rising to leadership among women were extracted and tabulated along with other pertinent study characteristics. DATA SYNTHESIS: The database searches generated 892 records. Thirty-nine studies met inclusion criteria for data extraction. The included articles represented seven countries, with 30 studies originating in the United States. Only two studies were from CCM, whereas others addressed leadership in other academic and clinical fields of medicine, medical journals, and societies and medical faculty. Twenty-six studies were qualitative, observational studies; five were survey based and eight included interviews. Using thematic analysis, the following five domains emerged: pipeline issues, lack of opportunities, lack of self-efficacy, lack of mentorship, and sustaining women in leadership. CONCLUSIONS: While the satisfaction rates of women in CCM were high, challenges remain for women to obtain leadership opportunities. A culture of support could better nurture and sustain women in leadership roles. More CCM-focused gender bias research is needed. Future targets for interventions include gender bias training, awareness, and developing strategies to break through the cycle of gender preferential promotions in CCM.
The hemodynamic effects of IV paracetamol in intensive care patients
Gabay, Ohad , Miller, Hodaya, Gruenbaum, Benjamin F. , Zafarov, Adam, Bichovsky, Yoav, Koyfman, Leonid, Brotfain, Evgeni , Gruenbaum, Benjamin Fredrick , Miller, Hodaya, Ashur, Avia, Frenkel, Amit , Koyfman, Leonid

Mayo Clinic

Journal of the Intensive Care Society | March 26, 2025 | Volume: 26 | Issue: 3 | Pages: 311-316

10.1177/17511437251327566 | PMID 40160308 Get It

Objective: This retrospective observational study conducted in a general ICU aimed to evaluate the hemodynamic impact of IV paracetamol by monitoring blood pressure, urine output, and core temperature post-administration. Design: The study was designed as a retrospective observational study in a general ICU setting. Setting: The study was conducted in a general intensive care unit (ICU). Patients: Data from 498 patients receiving IV paracetamol in various clinical contexts were analyzed. Interventions: Patients received IV paracetamol for analgesia and fever reduction as part of their clinical care. Measurements and main results: The study analyzed the hemodynamic effects of IV paracetamol by monitoring blood pressure, urine output, and core temperature post-administration. A significant decrease in mean systolic and diastolic blood pressure values was observed across different patient subgroups, notably 45–60 min post-infusion. An increase in noradrenaline dosage and a decrease in urine output indicated a decline in end-organ perfusion following IV paracetamol administration. Multivariate analysis identified associations between clinical factors (such as general anesthesia and cardiac conditions) and changes in blood pressure. Conclusions: While IV paracetamol remains a valuable therapeutic option for pain and fever management, especially in hypertensive patients with specific conditions like traumatic brain injury and cerebral vascular accident, careful monitoring, and individualized dosing strategies are recommended in critically ill patients to maintain hemodynamic stability and optimize clinical outcomes. These findings contribute to enhancing our understanding of IV paracetamol hemodynamic effects and inform evidence-based practices for its use in ICU settings.
Hypertension and Atrial Fibrillation: A Frontier Review From the AF-SCREEN International Collaboration
Schnabel, Renate B. , Schutte, Aletta E. , Buckley, Claire , Cameron, Alan C. , Damasceno, Albertino , Diederichsen, Søren Zöga , Doehner, Wolfram , Joung, Boyoung , Hankey, Graeme J. , Lobban, Trudie , Mairesse, Georges H. , Svendsen, Jesper Hastrup , Tieleman, Robert G , Wang, Ji‐Guang , Niiranen, Teemu J , Schnabel, Renate B , Schutte, Aletta E , Boriani, Giuseppe , Buckley, Claire , Cameron, Alan C , Damasceno, Albertino , Diederichsen, Søren Z , Doehner, Wolfram , Guo, Yutao , Hobbs, F D Richard , Joung, Boyoung , Hankey, Graeme J , Lip, Gregory Y H , Lobban, Trudie , Løchen, Maja-Lisa , Mairesse, Georges , Mbakwem, Amam , Noseworthy, Peter A , Steinhubl, Steven , Stergiou, George , Svendsen, Jesper Hastrup , Tieleman, Robert G , Wang, Ji-Guang , Poulter, Neil R , Healey, Jeffrey S , Freedman, Ben , Biton, Yitschak , Boriani, Giuseppe , Hobbs, Richard , Mbakwem, Amam , Noseworthy, Peter A. , Ntaios, George , Stergiou, George S. , Healey, Jeff S. , Freedman, Ben

Mayo Clinic

Circulation | March 24, 2025 | Volume: 151 | Issue: 12 | Pages: 863-877

10.1161/circulationaha.124.071047 | PMID 40127157 Get It

Hypertension is the leading modifiable risk factor for atrial fibrillation (AF) and is estimated to be present in >70% of AF patients. This Frontiers Review was prepared by 29 expert members of the AF-SCREEN International Collaboration to summarize existing evidence and knowledge gaps on links between hypertension, AF, and their cardiovascular sequelae; simultaneous screening for hypertension and AF; and the prevention of AF through antihypertensive therapy. Hypertension and AF are inextricably connected. Both are easily diagnosed, often silent, and frequently treated inadequately. Together, they additively increase the risk of ischemic stroke, heart failure, and many types of dementia, resulting in greater all-cause mortality, considerable disease burden, and increased health care expenditures. Automated upper arm cuff blood pressure devices with implemented technology can be used to simultaneously detect both hypertension and AF. However, positive screening for AF with an oscillometric blood pressure monitor still requires ECG confirmation. The current evidence suggests that high-risk individuals aged ≥65 years or with treatment-resistant hypertension could benefit from AF screening. Since antihypertensive therapy effectively lowers AF risk, particularly in individuals with left ventricular dysfunction, hypertension should be the key target for AF prediction and prevention rather than merely a comorbidity of AF. Nevertheless, several important gaps in knowledge need to be filled over the next years, including the ideal method and selection of patients for simultaneous screening of hypertension and AF and the optimal antihypertensive drug class and blood pressure targets for AF prevention.